CHILI 4.0

Conference on Hybrid Imaging Live

REGISTER NOW

Lectures

1
1 - NEW HORIZONS FOR HYBRID IMAGING

1 - NEW HORIZONS FOR HYBRID IMAGING

110:46CHILI 4.0

Total body PET/CT - key benefits and applications
Thomas Beyer, Vienna /AT

AI in multimodality hybrid imaging
Irène Buvat, Orsay /FR

Novel molecular imaging probes for oncologic imaging and what’s their translational potential
Andrew Scott

Round table discussion and Q&A

2
2 - ONCOLOGY 1: HYBRID IMAGING AS THE STANDARD OF CARE

2 - ONCOLOGY 1: HYBRID IMAGING AS THE STANDARD OF CARE

104:47CHILI 4.0

PET/CT in lymphoma – the standard of clinical care
Marius Mayerhöfer

Lung carcinoma – the challenges in staging and therapy monitoring
Helmut Prosch

Why PET/CT in HNSCC?
Andrew Scarsbrook

Melanoma: imaging-based therapeutic management
Marcus Unterrainer

Round table discussion and Q&A

3
Symposium  - LUNCH SYMPOSIUM (sponsored by Siemens Healthineers)

Symposium - LUNCH SYMPOSIUM (sponsored by Siemens Healthineers)

42:47CHILI 4.0

4
3 -  ONCOLOGY 2: THE WORLD BEYOND FDG

3 - ONCOLOGY 2: THE WORLD BEYOND FDG

105:27CHILI 4.0

Neuroendocrine tumors: therapeutic magagement with SSR-targeting tracers
Clemens Cyran

Prostate carcinoma: PSMA PET/CT in clinical decision guidance
Harun Ilhan

FAPI PET: the new FDG in solid tumors?
Frederik Giesel

FET PET/MRI in neuro-oncology
Jiří Ferda

Round table discussion and Q&A

5
Symposium  - VALUE OF CONTRAST ENHANCED CT IN HYBRID IMAGING (sponsored by Bayer)

Symposium - VALUE OF CONTRAST ENHANCED CT IN HYBRID IMAGING (sponsored by Bayer)

35:06Klaus Strobel

6
4 - INFECTION AND INFLAMMATION

4 - INFECTION AND INFLAMMATION

93:47CHILI 4.0

Rheumatological diseases: the role of hybrid imaging
Mona-Elisabeth Revheim

Prothesis infection – from aortic replacements to endoprothesis
Michel Eisenblätter

Specific tracers in imaging of inflammation
José Vercher-Conejero

Hybrid imaging in COVID-19: What have we learned?
Manil Subesinghe

Round table discussion and Q&A